Drug-Induced Hepatitis Following Albendazole Use: A Case Report and Literature Review
Fedaa Housen, Maryam Alkhatry, Haris Ejaz, Bashar Almasri, and Qonith Gibrata
Abstract
Albendazole is a broad-spectrum anthelmintic drug generally regarded as safe. Rarely, it may cause acute toxic hepatitis. We report a case of severe hepatotoxicity following albendazole use in a pediatric patient. Other causes of acute hepatitis were excluded, and the Roussel Uclaf Causality Assessment Method (RUCAM) score was 8, indicating a highly probable drug-induced liver injury.
Keywords: Albendazole; Drug-induced hepatitis; Hepatotoxicity; RUCAM; Anthelmintics.
Article DOI: https://doi.org/10.70620/CRROA/v7i1/154
Journal Information
| Online ISSN: | 2583-892X |
| Format of Publication | Online |
| Journal Abbreviation | Case Rep Rev Open Access |
| DOI | Via Crossref |
| DOI Prefix | 10.70620/CRROA/ |
| Journal Code | CRROA |
| Publishing Model | Continuous publishing |
| Frequency of Publication | Two Issue a Year |
| Language | English |
| Starting Year | 2020 |
| Subject | Clinical, Medical, Biomedical |
| Review Process | Single-Blind Peer-Review by Referees |
| Time to 1st Decision | 1 to 4 weeks from date of submission |
| Time to Acceptance | 3 to 6 weeks, depending upon the required revision cycles |
| Time to Publication | 1 to 2 weeks from date of final submission |
Journal Highlights
Journal Index
- Google Scholar (academic search)
- Semantic Scholar (academic literature discovery)
- Scilit (article-level metadata database)
- ResearchBib (Academic Resource Index)
- Crossref (DOI registration & metadata)
- WorldCat (library catalogues)
- Dimensions.ai (research discovery)
- OpenAIRE (open-science research discovery)
- CORE (repository aggregation)
Citation